SG11202105822WA - Achromosomal dynamic active systems - Google Patents

Achromosomal dynamic active systems

Info

Publication number
SG11202105822WA
SG11202105822WA SG11202105822WA SG11202105822WA SG11202105822WA SG 11202105822W A SG11202105822W A SG 11202105822WA SG 11202105822W A SG11202105822W A SG 11202105822WA SG 11202105822W A SG11202105822W A SG 11202105822WA SG 11202105822W A SG11202105822W A SG 11202105822WA
Authority
SG
Singapore
Prior art keywords
achromosomal
active systems
dynamic active
dynamic
systems
Prior art date
Application number
SG11202105822WA
Other languages
English (en)
Inventor
Adam Fisher
Kimberly Homan
Troy Hubbard
David Kolesky
Analise Reeves
Caitlin Spaulding
Hok Tam
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of SG11202105822WA publication Critical patent/SG11202105822WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202105822WA 2018-12-10 2019-12-10 Achromosomal dynamic active systems SG11202105822WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862777305P 2018-12-10 2018-12-10
PCT/US2019/065562 WO2020123569A1 (fr) 2018-12-10 2019-12-10 Systèmes actifs dynamiques achromosomiques

Publications (1)

Publication Number Publication Date
SG11202105822WA true SG11202105822WA (en) 2021-06-29

Family

ID=71077548

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105822WA SG11202105822WA (en) 2018-12-10 2019-12-10 Achromosomal dynamic active systems

Country Status (15)

Country Link
US (1) US20220031862A1 (fr)
EP (1) EP3893856A4 (fr)
JP (1) JP2022513709A (fr)
KR (1) KR20210101260A (fr)
CN (1) CN113498338A (fr)
AU (1) AU2019397460A1 (fr)
BR (1) BR112021011044A2 (fr)
CA (1) CA3121520A1 (fr)
CL (2) CL2021001466A1 (fr)
CO (1) CO2021008980A2 (fr)
EA (1) EA202191632A1 (fr)
IL (1) IL283510A (fr)
MX (1) MX2021006564A (fr)
SG (1) SG11202105822WA (fr)
WO (1) WO2020123569A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
BR112019022539A2 (pt) 2017-04-28 2020-06-16 Agrospheres, Inc. Composições e métodos para o encapsulamento e entrega escalonável de agorquímicos
BR112020005803A2 (pt) 2017-09-25 2020-12-01 Agrospheres, Inc. composições e métodos para produção e administração moduláveis de produtos biológicos
US20230242595A1 (en) * 2020-06-17 2023-08-03 Flagship Pioneering Innovations Vi, Llc Adas comprising bacterial secretion systems
AU2021292536A1 (en) * 2020-06-17 2023-02-02 Flagship Pioneering Innovations Vi, Llc. Methods for manufacturing ADAS
CN112342233B (zh) * 2020-11-10 2022-08-26 上海陶宇晟生物技术有限责任公司 用于细菌表达DacA时提高c-di-AMP产量的多核苷酸
WO2023164454A2 (fr) * 2022-02-22 2023-08-31 Board Of Regents For The Oklahoma Agricultural And Mechanical Colleges Compositions et procédés pour une transformation de plante médiée par rhizobium améliorée
WO2023250487A1 (fr) 2022-06-23 2023-12-28 Flagship Pioneering Innovations Vi, Llc Adas comprenant des pili de type 1
CN115851800A (zh) * 2022-09-20 2023-03-28 天津大学 一种提高希瓦氏菌电子传递能力的方法
WO2024107853A1 (fr) * 2022-11-15 2024-05-23 Flagship Pioneering Innovations Vi, Llc Systèmes achromosomiques actifs dynamiques optimisés et leurs utilisations
WO2024107843A1 (fr) 2022-11-15 2024-05-23 Flagship Pioneering Innovations Vi, Llc Systèmes actifs dynamiques achromosomiques stabilisés et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
LT2351772T (lt) * 2005-02-18 2016-10-10 Glaxosmithkline Biologicals Sa Baltymai ir nukleorūgštys iš su meningitu/sepsiu susijusių escherichia coli
ES2843402T3 (es) * 2011-12-13 2021-07-16 Engeneic Molecular Delivery Pty Ltd Minicélulas intactas de origen bacteriano para la administración de agentes terapéuticos a tumores cerebrales
WO2014138324A1 (fr) * 2013-03-07 2014-09-12 The General Hospital Corporation Compositions et procédés pour la délivrance bactérienne de polypeptides
BR112019022539A2 (pt) * 2017-04-28 2020-06-16 Agrospheres, Inc. Composições e métodos para o encapsulamento e entrega escalonável de agorquímicos

Also Published As

Publication number Publication date
BR112021011044A2 (pt) 2021-08-31
CL2021001466A1 (es) 2021-11-26
KR20210101260A (ko) 2021-08-18
MX2021006564A (es) 2021-08-11
CA3121520A1 (fr) 2020-06-18
JP2022513709A (ja) 2022-02-09
WO2020123569A1 (fr) 2020-06-18
AU2019397460A1 (en) 2021-06-17
CN113498338A (zh) 2021-10-12
EP3893856A1 (fr) 2021-10-20
IL283510A (en) 2021-07-29
EA202191632A1 (ru) 2021-12-06
CL2023001550A1 (es) 2023-11-03
CO2021008980A2 (es) 2021-07-30
EP3893856A4 (fr) 2022-10-05
US20220031862A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
IL283510A (en) Active dynamic chromosomal systems
EP3823796A4 (fr) Système d'amortissement actif
SG11202100791UA (en) Cross-blockchain interaction systems
EP3445978A4 (fr) Procédés et systèmes actifs de suppression des ondulations hydrauliques
IL252583B (en) An active defense system based on drones
GB201806508D0 (en) Systems
GB2568513B (en) Paging systems
PL3583101T3 (pl) Związki bis dla urządzeń aktywnych optycznie
EP3600263C0 (fr) Systèmes de microcellules pour l'administration de molécules actives
GB201816809D0 (en) Establishing access systems
EP3638878A4 (fr) Système d'exploitation dynamique de champ
EP3716265A4 (fr) Système de lutte active contre le bruit
EP3709980C0 (fr) Systèmes de microcellules pour l'administration de molécules actives hydrophiles
GB201911857D0 (en) Accumulator system
GB201501893D0 (en) Active suspension systems
GB2568433B (en) Dynamic projection system
ZA202005055B (en) Load retention system
ZA202003139B (en) Active breathing system
GB202114885D0 (en) Earphone systems
EP3841406A4 (fr) Système dynamique d'opérations sur le terrain
EP3721554A4 (fr) Système de limitation actif
AU2018294353A1 (en) Active control system
GB2566699B (en) Active suspension device
GB201903938D0 (en) Dynamic systems
GB201707570D0 (en) Dynamic systems